• Tel: 858.663.9055
  • SeparatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
Home >> Antibodies >> CD8A Antibody for FACS / Human PBMC Flow Cytometry Antibody

CD8A Antibody for FACS / Human PBMC Flow Cytometry Antibody [clone CD8/3892R] (V8521)

  Catalog No Formulation Size Price (USD)  
Image V8521-100UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 100 ug 559
Image
V8521-20UG 0.2 mg/ml in 1X PBS with 0.1 mg/ml BSA (US sourced) and 0.05% sodium azide 20 ug 259
Image
V8521SAF-100UG 1 mg/ml in 1X PBS; BSA free, sodium azide free 100 ug 559
Microvalidated Recrabbitmono
Bulk quote request
CD8A Antibody for FACS - Human PBMC lymphocyte gating. Flow cytometry analysis of CD8 alpha (CD8A) in human lymphocyte-gated PBMC shows a clear right-shifted population (red) relative to isotype control (gray), consistent with cell surface expression on cytotoxic T lymphocytes and enabling accurate identification and gating of CD8-positive T cell populations within heterogeneous peripheral blood samples (clone CD8/3892R).
Availability 1-3 business days
Species Reactivity Human
Format Purified
Host Rabbit
Clonality Recombinant Rabbit Monoclonal
Isotype Rabbit IgG
Clone Name CD8/3892R
Purity Protein A affinity chromatography
UniProt P01732
Localization Cell surface
Applications ELISA : order Ab without BSA for coating
Flow Cytometry : 1-2ug/million cells
Limitations This CD8A Antibody for FACS / Human PBMC Flow Cytometry Antibody is available for research use only.
Review this product on BioCompare and get a $20 Amazon gift card

Related Products

Description

CD8 alpha (CD8A) is a transmembrane glycoprotein expressed on cytotoxic T lymphocytes where it functions as a co-receptor for T cell receptor signaling through interaction with MHC class I molecules. CD8A Antibody for FACS is widely used to detect CD8 alpha on the surface of human peripheral blood mononuclear cells (PBMC), enabling precise identification and quantification of cytotoxic T cell populations by flow cytometry. CD8A antibody, also referred to as CD8 alpha antibody or CD8 antigen antibody, is a core immune marker for defining CD8-positive T cell subsets in human samples.

CD8A is localized to the plasma membrane and is readily accessible for antibody binding in flow cytometry applications, allowing robust cell surface staining without the need for fixation or permeabilization. In FACS analysis of human PBMC, CD8A staining produces a clearly resolved positive population corresponding to cytotoxic T lymphocytes, enabling accurate gating strategies and separation of CD8-positive cells from other immune populations such as CD4-positive helper T cells and non-T cell subsets. This makes CD8A Antibody for FACS essential for high-resolution immune profiling and subset discrimination.

This recombinant rabbit monoclonal antibody, clone CD8/3892R, is optimized for flow cytometry and demonstrates strong performance in human PBMC, providing reliable detection of endogenous CD8A expression in primary immune cells. Validation in peripheral blood-derived samples ensures biological relevance and supports consistent performance in studies involving fresh or processed human immune cell populations. The recombinant monoclonal format contributes to lot-to-lot consistency and high specificity in flow cytometry assays.

CD8A Antibody for FACS is particularly valuable in studies of immune monitoring, where quantification of cytotoxic T cells is critical for assessing immune status, disease progression, and response to therapy. Flow cytometry detection of CD8A is widely used in oncology, infectious disease research, and immunotherapy studies, where changes in CD8-positive T cell populations provide key biological insights. The ability to detect CD8A on viable cells also enables downstream applications such as fluorescence-activated cell sorting (FACS), supporting isolation of cytotoxic T cell populations for functional assays and molecular analysis.

CD8A flow cytometry antibody staining is frequently combined with additional markers such as CD3 antibody to define total T cells, CD4 antibody to distinguish helper T cell subsets, and checkpoint markers including PD-1 or PD-L1 to assess activation or exhaustion states. This multi-parameter approach enables comprehensive characterization of immune cell composition and function within PBMC samples. The combination of strong surface staining, reproducible performance, and compatibility with complex gating strategies makes CD8A Antibody for FACS a critical reagent for human immune profiling workflows.

This antibody is part of a broader selection of immune cell marker antibodies designed to support studies of T cell biology, immune infiltration, and tumor immunology, including application-specific CD8A antibody reagents for IHC, FACS, WB, and IF.

Application Notes

Optimal dilution of the CD8A Antibody for FACS / Human PBMC Flow Cytometry Antibody should be determined by the researcher.

Immunogen

Recombinant human full-length protein was used as the immunogen for the recombinant CD8A antibody.

Storage

Store the recombinant CD8A antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Alternate Names

CD8A FACS antibody, CD8 alpha flow cytometry antibody, CD8A human PBMC antibody, CD8A cell surface marker antibody, CD8A recombinant rabbit antibody

Cross
Bulk Quote Request Form
Name*:
Organization*:
Email*:
Phone Number*:
Catalog No.*:
Comments and Specifics(amount, formulation, etc.)*:
Validation code: Captchapackage Image


Can't read the image? click here to refresh.
    *required field

Your bulk quote request has been submitted successfully!

Please contact us if you have any questions.